We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Endpoint Health Stock

Invest in or calculate the value of your shares in Endpoint Health or other pre-IPO companies through EquityZen's platform.

Get Started

Endpoint Health Stock (ENDH)

Endpoint Health is a biotechnology company that develops precision medicine and integrated therapies for critical care.

About Endpoint Health Stock

Founded

2018

Headquarters

Palo Alto, CA, US

Industries

Software, Artificial Intelligence, Data and Analytics

Endpoint Health is a biotechnology company that develops precision medicine and integrated therapies for critical care. The company's precision approaches to deeply understanding patients' immune states and using that knowledge to develop precision therapies are exactly the type of innovation needed. To develop precision therapies for patients with immune-mediated conditions such as acute respiratory distress syndrome (ARDS), sepsis, rheumatic and gastroenterologic diseases, researchers are combining therapeutics, therapy-guiding tests, and AI. Endpoint Health was built from the ground up to develop and commercialize therapeutics and therapy-guiding tests, ensuring that every patient receives personalized care that significantly improves their outcomes.

Endpoint Health Press Mentions

Stay in the know about the latest news on Endpoint Health

Endpoint Health Management

Leadership team at Endpoint Health

Board of Directors

Ursheet Parikh

CSO

Diego Rey

Locked Features

Join now and verify your accreditation status to gain access to:

  • Endpoint Health current valuation
  • Endpoint Health stock price
  • Available deals in Endpoint Health and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Endpoint Health stock?

Accredited investors can buy pre-IPO stock in companies like Endpoint Health through EquityZen funds. These investments are made available by existing Endpoint Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Endpoint Health stock?

Shareholders can sell their Endpoint Health stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."